Saturna Capital Corp Novo Nordisk A S Transaction History
Saturna Capital Corp
- $7.24 Billion
- Q4 2024
A detailed history of Saturna Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Saturna Capital Corp holds 2,111,948 shares of NVO stock, worth $192 Million. This represents 2.51% of its overall portfolio holdings.
Number of Shares
2,111,948
Previous 2,132,038
0.94%
Holding current value
$192 Million
Previous $254 Million
28.44%
% of portfolio
2.51%
Previous 3.38%
Shares
27 transactions
Others Institutions Holding NVO
# of Institutions
1,881Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.81 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.41 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.18 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.15 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.11 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $205B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...